Tags

Type your tag names separated by a space and hit enter

Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
Clin Med (Lond). 2020 07; 20(4):e59.CM

Links

PMC Free PDF

Authors+Show Affiliations

Pooni RS
Newham University Hospital, London, UK.

MeSH

AnticoagulantsBetacoronavirusBiomarkersBlood Coagulation DisordersCOVID-19Case-Control StudiesCoronavirus InfectionsFibrin Fibrinogen Degradation ProductsHeparin, Low-Molecular-WeightHumansPandemicsPartial Thromboplastin TimePneumonia, ViralRisk FactorsSARS-CoV-2ThrombophiliaVenous Thromboembolism

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32675158

Citation

Pooni, Rajan S.. "Research in Brief: Coagulopathy in COVID-19: Determining and Managing Thrombotic Risk in COVID-19 Infection." Clinical Medicine (London, England), vol. 20, no. 4, 2020, pp. e59.
Pooni RS. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection. Clin Med (Lond). 2020;20(4):e59.
Pooni, R. S. (2020). Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection. Clinical Medicine (London, England), 20(4), e59. https://doi.org/10.7861/clinmed.rib.20.4.2
Pooni RS. Research in Brief: Coagulopathy in COVID-19: Determining and Managing Thrombotic Risk in COVID-19 Infection. Clin Med (Lond). 2020;20(4):e59. PubMed PMID: 32675158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection. A1 - Pooni,Rajan S, PY - 2020/7/18/entrez PY - 2020/7/18/pubmed PY - 2020/8/4/medline SP - e59 EP - e59 JF - Clinical medicine (London, England) JO - Clin Med (Lond) VL - 20 IS - 4 SN - 1473-4893 UR - https://www.unboundmedicine.com/medline/citation/32675158/Research_in_brief:_Coagulopathy_in_COVID_19:_Determining_and_managing_thrombotic_risk_in_COVID_19_infection_ DB - PRIME DP - Unbound Medicine ER -